دارویی ره آورد تامین
درهآور | Stocks - Iran Fara Bourse (IFB)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 14,040 2.77
Close Price: 14,010
Income Statement
AGM
Interim
2026/06/17 Fiscal Year 2026/03/2012 Month | 2025/05/06 Fiscal Year 2025/03/2012 Month | 2024/05/07 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 12.83 Trillion | 9.039 Trillion | 8.522 Trillion | |
Total Revenues | 12.83 Trillion | 9.039 Trillion | 8.522 Trillion | |
Cost of Goods Sold | 6.506 Trillion | 4.47 Trillion | 4.17 Trillion | |
Gross Profit | 6.324 Trillion | 4.569 Trillion | 4.352 Trillion | |
General & Administrative Expenses | 743.25 Billion | 489.77 Billion | 302.672 Billion | |
Net Operating Income & Expenses | - | -21 Million | - | |
Operating Profit (Loss) | 5.581 Trillion | 4.08 Trillion | 4.049 Trillion | |
Profit Before Tax | 5.135 Trillion | 3.96 Trillion | 3.863 Trillion | |
Tax | 767.613 Billion | 552.098 Billion | 753.246 Billion | |
Net Profit (Loss) After Tax | 4.368 Trillion | 3.408 Trillion | 3.11 Trillion | |
Retained Earnings at Beginning of Period | 3.427 Trillion | - | 2.552 Trillion | |
Approved Dividends — Prior Year AGM | -2.702 Trillion | -2.175 Trillion | -2.297 Trillion | |
Allocable Profit | 5.093 Trillion | 1.233 Trillion | 3.365 Trillion | |
Legal Reserve | 72.151 Billion | - | - | |
Approved Dividends — Current Year | 3.986 Trillion | 2.702 Trillion | 2.175 Trillion | |
Retained Earnings at End of Period | 1.035 Trillion | -1.469 Trillion | 1.19 Trillion |